The graft was successfully implanted on (b)(6) 2022.The issue was identified during a follow-up visit on (b)(6) 2022.As a result, there was no reported adverse event associated with this complaint.Based on the documentation and complaint history review, we do not believe there is a systemic issue with this device.Manufacturing records and necessary logs were reviewed and no deviations or non-confomances were found.This is the only event related to a"dissection flap" in product history.All available information has been provided.This and similar complaints will continue to be monitored and investigated.Additional actions will be performed as deemed necessary.
|